Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Colorectal Cancer.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT00506207
What this trial is testing

A Phase I Study of S-1 Plus Irinotecan and Oxaliplatin in Advanced Gastrointestinal Malignancy

Who this might be right for
Colorectal NeoplasmGastric NeoplasmSecondary
National Cancer Center, Korea 23
Not applicableUnknownNCT04500392
What this trial is testing

High-flow Nasal Cannula Oxygenation Decrease Hypoxia in Sedated Gastrointestinal Endoscopes in Obesity

Who this might be right for
HypoxiaGastric CancerEsophagus Cancer+2 more
RenJi Hospital 1,000
Early research (Phase 1)Study completedNCT02387307
What this trial is testing

RSIFN-co in Subjects With Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small-Cell LungCarcinoma, Renal CellMelanoma+2 more
Sichuan Huiyang Life Science and Technology Corporation 42
Testing effectiveness (Phase 2)Ended earlyNCT04171700
What this trial is testing

Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes

Who this might be right for
Solid Tumor
pharmaand GmbH 83
Testing effectiveness (Phase 2)Study completedNCT03890731
What this trial is testing

A Clinical Study of Regorafenib in Participants Who Have Been Treated in Previous Bayer-sponsored Regorafenib Studies That Have Been Completed

Who this might be right for
Solid Cancer
Bayer 6
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06783153
What this trial is testing

Efficacy and Safety of Adjunctive Use of Rifaximin In Preventing Radiotherapy-induced Diarrhea in Cancer Patients

Who this might be right for
Radiotherapy Induced DiarrheaAcute Radiation EnteritisProstate Cancer+5 more
Mansoura University 80
Large-scale testing (Phase 3)Active Not RecruitingNCT01349881
What this trial is testing

S0820, Adenoma and Second Primary Prevention Trial

Who this might be right for
Colorectal Neoplasms
SWOG Cancer Research Network 354
Not applicableWithdrawnNCT03413930
What this trial is testing

Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer

Who this might be right for
Rectal Cancer
Ruijin Hospital
Testing effectiveness (Phase 2)Study completedNCT01108107
What this trial is testing

Neoadjuvant Treatment of Colon Cancer

Who this might be right for
Colon Cancer
Vejle Hospital 76
Testing effectiveness (Phase 2)Ended earlyNCT01508000
What this trial is testing

Efficacy of FOLFOX Alone, FOLFOX Plus Bevacizumab and FOLFOX Plus Panitumumab in Patients With Resectable Liver Metastases

Who this might be right for
Colorectal Cancer MetastaticLiver MetastasesKRAS Wild Type Colorectal Cancer
European Organisation for Research and Treatment of Cancer - EORTC 44
Post-approval studies (Phase 4)Study completedNCT02567331
What this trial is testing

Capecitabine (Xeloda) in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 28
Not applicableUnknownNCT02553031
What this trial is testing

Application of MR-PET in Colorectal Cancer

Who this might be right for
Colorectal Cancer
National Taiwan University Hospital 100
Large-scale testing (Phase 3)Not Yet RecruitingNCT07025239
What this trial is testing

QL1706 Injection Plus Bevacizumab and XELOX vs Placebo Plus Bevacizumab and XELOX as First-Line Treatment of Unresectable Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Qilu Pharmaceutical Co., Ltd. 430
Testing effectiveness (Phase 2)Looking for participantsNCT07728019
What this trial is testing

Efficacy and Safety of Retlirafusp Alfa Plus Bevacizumab and Chemotherapy With or Without Short-Course Radiotherapy in Patients With CRCLM

Who this might be right for
CRC (Colorectal Cancer)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 60
Testing effectiveness (Phase 2)Study completedNCT01909830
What this trial is testing

Gemcitabine in Combination With Pemetrexed Long Term Infusion in the Treatment of Pretreated Metastatic Colorectal Cancer Patients

Who this might be right for
Colorectal Cancer Metastatic
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 18
Early research (Phase 1)UnknownNCT00250328
What this trial is testing

Evaluation of NiTi Laparoscopic Compression Anastomosis Clip (LapCAC) Device for Intra-Corporeal Lap-Colectomy

Who this might be right for
Colon Cancer
Hadassah Medical Organization 40
Not applicableWithdrawnNCT03633539
What this trial is testing

Single-incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer

Who this might be right for
Colorectal CancerColonic NeoplasmsRectal Neoplasms+4 more
Ruijin Hospital
Large-scale testing (Phase 3)Study completedNCT01607957
What this trial is testing

Study of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies

Who this might be right for
Colorectal Cancer
Taiho Oncology, Inc. 800
Not applicableStudy completedNCT02022553
What this trial is testing

Procedure RACHEL in Complex Treatment of Rectal Cancer

Who this might be right for
Rectal Cancer T3-4N0-2M0
Voronezh N.N. Burdenko State Medical Academy 52
Not applicableWithdrawnNCT01882972
What this trial is testing

Strength for Health

Who this might be right for
Colon Cancer
Loyola University
Next Page